XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenues:        
Total revenues $ 254.7 $ 337.9 $ 555.1 $ 502.2
Operating expenses:        
Cost of goods and services sold 296.1 190.6 440.7 343.5
Impairment of long-lived assets 27.2 306.7 27.2 306.7
Research and development 32.7 26.0 47.8 66.7
Selling, general and administrative 85.9 91.4 170.6 192.7
Amortization of intangible assets 16.3 16.1 32.5 33.1
Total operating expenses 458.2 630.8 718.8 942.7
Loss from operations (203.5) (292.9) (163.7) (440.5)
Other income (expense):        
Interest expense (23.6) (28.6) (47.9) (46.5)
Gain (loss) on sale of business and assets held for sale (40.0) 74.9 (40.0) 74.9
Other, net (2.7) (3.6) (6.1) 1.3
Total other income (expense), net (66.3) 42.7 (94.0) 29.7
Loss before income taxes (269.8) (250.2) (257.7) (410.8)
Income tax provision 13.3 11.2 16.4 36.8
Net loss $ (283.1) $ (261.4) $ (274.1) $ (447.6)
Net loss per common share        
Basic (in dollars per share) $ (5.38) $ (5.16) $ (5.23) $ (8.86)
Diluted (in dollars per share) $ (5.38) $ (5.16) $ (5.23) $ (8.86)
Weighted average shares outstanding        
Basic (in shares) 52.6 50.7 52.4 50.5
Diluted (in shares) 52.6 50.7 52.4 50.5
Total Product sales, net        
Revenues:        
Product sales $ 183.4 $ 302.2 $ 457.3 $ 445.6
Commercial Product sales        
Revenues:        
Product sales 120.0 137.9 238.5 244.1
Operating expenses:        
Cost of goods and services sold 53.4 54.4 105.5 100.2
MCM Product sales        
Revenues:        
Product sales 63.4 164.3 218.8 201.5
Operating expenses:        
Cost of goods and services sold 31.1 80.5 93.3 135.9
Total Bioservices revenues        
Revenues:        
Total Bioservices revenues 64.7 29.1 83.2 43.5
Operating expenses:        
Cost of goods and services sold 211.6 55.7 241.9 107.4
Services        
Revenues:        
Product sales 64.5 26.4 82.8 39.0
Leases        
Revenues:        
Leases 0.2 2.7 0.4 4.5
Contracts and grants        
Revenues:        
Product sales $ 6.6 $ 6.6 $ 14.6 $ 13.1